These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23478537)

  • 41. A large, benign prostatic cyst presented with an extremely high serum prostate-specific antigen level.
    Chen HK; Pemberton R
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26746834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions.
    Nordström T; Adolfsson J; Grönberg H; Eklund M
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27418620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
    Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels.
    Kuriyama M; Uno H; Watanabe H; Yamanaka H; Saito Y; Shida K
    Jpn J Clin Oncol; 1999 Dec; 29(12):617-22. PubMed ID: 10721944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy.
    Singh R; Cahill D; Popert R; O'Brien TS
    BJU Int; 2003 Dec; 92(9):932-5. PubMed ID: 14632850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [How to use PSA in 2009].
    Ponholzer A; Stoiber F; Loidl W; Rauchenwald M; Schramek P; Madersbacher S
    Wien Med Wochenschr; 2009; 159(21-22):515-20. PubMed ID: 19997836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
    Djavan B; Zlotta AR; Remzi M; Ghawidel K; Bursa B; Hruby S; Wolfram R; Schulman CC; Marberger M
    Urology; 1999 Nov; 54(5):846-52. PubMed ID: 10565745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PSA scores: should we use a lower threshold?
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
    [No Abstract]   [Full Text] [Related]  

  • 51. Defining prostate cancer risk before prostate biopsy.
    Pal RP; Maitra NU; Mellon JK; Khan MA
    Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
    Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
    Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program.
    Nichols JH; Loeb S; Metter EJ; Ferrucci L; Carter HB
    BJU Int; 2012 May; 109(9):1304-8. PubMed ID: 22093443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
    Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
    Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management.
    Benson MC; Olsson CA
    Cancer; 1994 Sep; 74(6):1667-73. PubMed ID: 7521783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.
    Morote J; Trilla E; Esquena S; Serrallach F; Abascal JM; Muñoz A; Id M'Hammed Y; de Torres IM
    Eur Urol; 2002 Oct; 42(4):333-7. PubMed ID: 12361897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of prostatic specific antigen in men with prostate disease. An elevated PSA level may indicate prostate cancer--and it may not.
    Wozniak-Petrofsky J
    Geriatr Nurs; 1993; 14(3):150-1. PubMed ID: 7685308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prostate-specific antigen. The role in the prostate cancer diagnosis].
    Sánchez-Martínez LC; Paredes-Solís CA; Hernández-Ordóñez OF; Sánchez-Ruvalcaba IR
    Rev Med Inst Mex Seguro Soc; 2013; 51(2):124-6. PubMed ID: 23693096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.